Xinglei Shen, MD
Radiation Oncology · Kansas City, KSNPI 1972797967
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Janssen Scientific Affairs, LLC at 58.8% of the total. Reporting peaked in 2022 at $9,079 and has fallen 98.0% since, to $182 in 2025. Among radiation oncology clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 16 payments — averaging $975.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$9K
- Myovant Sciences Inc.$4K
- Telix Pharmaceuticals$893
- Mevion_medical_systems_inc$836
- Pfizer$397
- Radformation Inc$350
- plus $56 from 2 others
Across 43 payments — averaging $17,833 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$425K
- Pfizer$182K
- Sumitomo Pharma America, Inc.$126K
- Bayer$34K
What the payments were for
- Consulting fees$9,17059%
- Speaking & faculty fees$4,25027%
- Travel & lodging$1,2988%
- Food & beverage$8846%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 3 | $9,170 |
| Myovant Sciences Inc. | 1 | $3,900 |
| Telix Pharmaceuticals | 1 | $893 |
| Mevion_medical_systems_inc | 5 | $836 |
| Pfizer | 3 | $397 |
| Radformation Inc | 1 | $350 |
| Teleflex LLC | 1 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,602 in reported general payments places this provider in the 95th percentile of 54 radiation oncology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 103 | $266,517 |
| Tamsulosin Hcl | 90 | $1,861 |
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $237 |
| Methylprednisolone | 16 | $129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Orgovyx | $23 | $266,517103 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 54 radiation oncology providers in Kansas.
Other radiation oncology in Kansas City
- Ronald ChenKansas City$31K
- David AkhavanKansas City$9K
- Fen WangKansas City$7K
- Gregory GanKansas City$5K
- Ronny RotondoKansas City$4K
- Jay ShiaoKansas City$3K
- Parvesh KumarKansas City$3K
- Ryan MorseKansas City$939
- Christopher LominskaKansas City$466
- Ramesh GadamKansas City$266
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.